EP1844158A4 - Biomarker für entzündliche darmerkrankung - Google Patents

Biomarker für entzündliche darmerkrankung

Info

Publication number
EP1844158A4
EP1844158A4 EP05853365A EP05853365A EP1844158A4 EP 1844158 A4 EP1844158 A4 EP 1844158A4 EP 05853365 A EP05853365 A EP 05853365A EP 05853365 A EP05853365 A EP 05853365A EP 1844158 A4 EP1844158 A4 EP 1844158A4
Authority
EP
European Patent Office
Prior art keywords
biomarker
inflammatory bowel
bowel disease
disease
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05853365A
Other languages
English (en)
French (fr)
Other versions
EP1844158A2 (de
Inventor
Chakravarti Shukti
Feng Wu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Publication of EP1844158A2 publication Critical patent/EP1844158A2/de
Publication of EP1844158A4 publication Critical patent/EP1844158A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
EP05853365A 2004-12-06 2005-12-06 Biomarker für entzündliche darmerkrankung Withdrawn EP1844158A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63366204P 2004-12-06 2004-12-06
PCT/US2005/044423 WO2006063133A2 (en) 2004-12-06 2005-12-06 Biomarker for inflammatory bowel disease

Publications (2)

Publication Number Publication Date
EP1844158A2 EP1844158A2 (de) 2007-10-17
EP1844158A4 true EP1844158A4 (de) 2010-09-08

Family

ID=36578568

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05853365A Withdrawn EP1844158A4 (de) 2004-12-06 2005-12-06 Biomarker für entzündliche darmerkrankung

Country Status (2)

Country Link
EP (1) EP1844158A4 (de)
WO (1) WO2006063133A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008011305A (es) * 2006-03-09 2009-02-10 Salix Pharmaceuticals Inc Preparacion anti-disfunsion rectal con rifaximina.
US20100267575A1 (en) * 2006-10-17 2010-10-21 Childrens Hospital Medical Center Gene array technique for predicting response in inflammatory bowel diseases
WO2008079406A2 (en) * 2006-12-19 2008-07-03 Genentech, Inc. Gene expression markers for inflammatory bowel disease
EP2148943B1 (de) * 2007-04-30 2016-10-05 Janssen Biotech, Inc. Methoden zur untersuchung und behandlung von colitis ulcerosa und verwandten erkrankungen unter anwendung eines panels mit 19 genen
WO2008147900A2 (en) * 2007-05-22 2008-12-04 Genentech, Inc. Gene expression markers for inflammatory bowel disease
WO2008147869A2 (en) 2007-05-22 2008-12-04 Centocor, Inc. Markers and methods for assessing and treating crohn's disease and related disorders
US8663927B2 (en) 2007-09-10 2014-03-04 University Of Kentucky Research Foundation Systems and methods for diagnosis and monitoring of bacteria-related conditions
US9040051B2 (en) * 2007-10-02 2015-05-26 Universitaet Zu Koeln Marker genes for regulatory T cells from human blood
AU2008334095A1 (en) * 2007-11-29 2009-06-11 Genentech, Inc. Gene expression markers for inflammatory bowel disease
JP5832903B2 (ja) 2009-01-19 2015-12-16 ビオメリューＢｉｏｍｅｒｉｅｕｘ 院内感染罹患の患者の易罹患性を判定し、敗血症症候群の進行の予後を確立する方法
EP2456890A1 (de) * 2009-07-20 2012-05-30 Genentech, Inc. Genexpressionsmarker für morbus crohn
WO2011127351A1 (en) * 2010-04-09 2011-10-13 Exagen Diagnostics, Inc. Biomarkers for ulcerative colitis and crohn's disease
CN112941150A (zh) * 2021-03-25 2021-06-11 安徽医科大学 一种筛选溃疡性结肠炎疾病活动度指标的方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000014283A2 (en) * 1998-09-04 2000-03-16 Washington University Gene markers for chronic mucosal injury
US6150096A (en) * 1997-09-26 2000-11-21 Universite De Sherbrooke Molecular markers for the diagnosis of human diseases including Crohn's disease
WO2002059367A2 (en) * 2000-11-30 2002-08-01 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Diagnostic microarray for inflammatory bowel disease, crohn's disease and ulcerative colitis
WO2002077651A1 (fr) * 2001-03-27 2002-10-03 Centre Hospitalier Regional Universitaire De Lille Methode de diagnostic de maladies inflammatoires chroniques de l'intestin
US6632617B1 (en) * 1997-05-13 2003-10-14 Incyte Corporation Tumor-associated antigen
WO2004001073A1 (en) * 2002-06-25 2003-12-31 Index Pharmaceuticals Ab Method and kit for the diagnosis of ulcerative colitis
WO2004058042A2 (en) * 2002-12-30 2004-07-15 Yeda Research And Development Co. Ltd. Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases
WO2004065577A2 (en) * 2003-01-14 2004-08-05 Bristol-Myers Squibb Company Polynucleotides and polypeptides associated with the nf-kb pathway

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2774769B2 (ja) * 1993-04-26 1998-07-09 賢治 寒川 アドレノメデュリン

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632617B1 (en) * 1997-05-13 2003-10-14 Incyte Corporation Tumor-associated antigen
US6150096A (en) * 1997-09-26 2000-11-21 Universite De Sherbrooke Molecular markers for the diagnosis of human diseases including Crohn's disease
WO2000014283A2 (en) * 1998-09-04 2000-03-16 Washington University Gene markers for chronic mucosal injury
WO2002059367A2 (en) * 2000-11-30 2002-08-01 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Diagnostic microarray for inflammatory bowel disease, crohn's disease and ulcerative colitis
WO2002077651A1 (fr) * 2001-03-27 2002-10-03 Centre Hospitalier Regional Universitaire De Lille Methode de diagnostic de maladies inflammatoires chroniques de l'intestin
WO2004001073A1 (en) * 2002-06-25 2003-12-31 Index Pharmaceuticals Ab Method and kit for the diagnosis of ulcerative colitis
WO2004058042A2 (en) * 2002-12-30 2004-07-15 Yeda Research And Development Co. Ltd. Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases
WO2004065577A2 (en) * 2003-01-14 2004-08-05 Bristol-Myers Squibb Company Polynucleotides and polypeptides associated with the nf-kb pathway

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HINSON J P ET AL: "Adrenomedullin, a multifunctional regulatory peptide.", ENDOCRINE REVIEWS, vol. 21, no. 2, April 2000 (2000-04-01), pages 138 - 167, XP002590796, ISSN: 0163-769X *

Also Published As

Publication number Publication date
WO2006063133A2 (en) 2006-06-15
EP1844158A2 (de) 2007-10-17
WO2006063133A3 (en) 2009-04-02

Similar Documents

Publication Publication Date Title
EP1844158A4 (de) Biomarker für entzündliche darmerkrankung
EP2089712A4 (de) Biomarker für autoimmunerkrankungen
EP1806581A4 (de) Krankheitsdiagnosesystem
EP1924190A4 (de) Anoskop
EP1907747A4 (de) Zwischendichtung für ausdehnbare verbindungen
IL206014A0 (en) Gene expression markers for inflammatory bowel disease
EP1815872A4 (de) Zusammensetzung für die diagnose von amyloid-assoziierter erkrankung
GB0702117D0 (en) Early Entry
EP1943071A4 (de) Vorrichtung zur bildung von hohlräumen
EP1891893A4 (de) System zur unterstützung der krankheitsbeurteilung
EP1801310A4 (de) Auskleidungsstruktur
ZA200801678B (en) Treatment of inflammatory bowel disease
EP1806145A4 (de) Mittel zur behandlung von entzündlichen erkrankungen
EP1952138A4 (de) Verfahren zur erkennung einer entzündungskrankheit oder einer krebserkrankung
GB0618127D0 (en) Biomarker
AU304410S (en) Bidet
EP2044957A4 (de) Mittel zur behandlung von entzündlicher darmerkrankung
GB0511302D0 (en) Biomarkers
EP2034305A4 (de) Verfahren zur bestimmung von entzündlicher darmerkrankung
GB2410799B (en) Fluid-gauging probes
IL215528A0 (en) Improved immunoassay methods
ZA200703666B (en) Biomarker for heart failure
EP1941874A4 (de) Therapeutisches mittel zur abgabe im kolon gegen entzündliche darmerkrankung
EP1667677A4 (de) Zusammensetzung zur behandlung von entzündlicher darmerkrankung
GB0521360D0 (en) Biomarker

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

DAX Request for extension of the european patent (deleted)
R17D Deferred search report published (corrected)

Effective date: 20090402

RIC1 Information provided on ipc code assigned before grant

Ipc: C07D 487/00 20060101ALI20090608BHEP

Ipc: A61K 38/00 20060101ALI20090608BHEP

Ipc: A01N 37/18 20060101ALI20090608BHEP

Ipc: C07K 16/00 20060101ALI20090608BHEP

Ipc: C12M 1/34 20060101ALI20090608BHEP

Ipc: G01N 33/53 20060101ALI20090608BHEP

Ipc: C12P 19/34 20060101ALI20090608BHEP

Ipc: C12Q 1/68 20060101AFI20090608BHEP

17P Request for examination filed

Effective date: 20091002

RBV Designated contracting states (corrected)

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20100810

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110308